Beta-amyloid plaques: stages in life history or independent origin?
- PMID: 9681645
- DOI: 10.1159/000017051
Beta-amyloid plaques: stages in life history or independent origin?
Abstract
Several types of discrete beta-amyloid (Abeta) deposit or senile plaque have been identified in the brains of individuals with Alzheimer's disease and Down's syndrome. The majority of these plaques can be classified into four morphological types: diffuse, primitive, classic and compact. Two hypotheses have been proposed to account for these plaques. Firstly, that the diffuse, primitive, classic and compact plaques develop in sequence and represent stages in the life history of a single plaque type. Secondly, that the different Abeta plaques develop independently and therefore, unique factors are involved in the formation of each type. To attempt to distinguish between these hypotheses, the morphology, ultrastructure, composition, and spatial distribution in the brain of the four types of plaque were compared. Although some primitive plaques may develop from diffuse plaques, the evidence suggests that a unique combination of factors is involved in the pathogenesis of each plaque type and, therefore, supports the hypothesis that the major types of Abeta plaque develop independently.
Similar articles
-
A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.Prog Clin Biol Res. 1989;317:313-23. Prog Clin Biol Res. 1989. PMID: 2532370
-
Label-free vibrational imaging of different Aβ plaque types in Alzheimer's disease reveals sequential events in plaque development.Acta Neuropathol Commun. 2020 Dec 11;8(1):222. doi: 10.1186/s40478-020-01091-5. Acta Neuropathol Commun. 2020. PMID: 33308303 Free PMC article.
-
Elimination of amyloid precursor protein in senile plaques in the brain of a patient with Alzheimer-type dementia and Down syndrome.Brain Dev. 2019 Jan;41(1):106-110. doi: 10.1016/j.braindev.2018.07.017. Epub 2018 Aug 4. Brain Dev. 2019. PMID: 30086988
-
Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease.J Mol Neurosci. 2001 Oct;17(2):137-45. doi: 10.1385/JMN:17:2:137. J Mol Neurosci. 2001. PMID: 11816787 Review.
-
[Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].Yakugaku Zasshi. 2017;137(7):801-805. doi: 10.1248/yakushi.16-00236-2. Yakugaku Zasshi. 2017. PMID: 28674290 Review. Japanese.
Cited by
-
Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations.Mol Neurodegener. 2008 Nov 20;3:20. doi: 10.1186/1750-1326-3-20. Mol Neurodegener. 2008. PMID: 19021905 Free PMC article.
-
Following spatial Aβ aggregation dynamics in evolving Alzheimer's disease pathology by imaging stable isotope labeling kinetics.Sci Adv. 2021 Jun 16;7(25):eabg4855. doi: 10.1126/sciadv.abg4855. Print 2021 Jun. Sci Adv. 2021. PMID: 34134980 Free PMC article.
-
Analysis of beta-amyloid (Abeta) deposition in the temporal lobe in Alzheimer's disease using Fourier (spectral) analysis.Neuropathol Appl Neurobiol. 2010 Apr;36(3):248-57. doi: 10.1111/j.1365-2990.2010.01071.x. Epub 2010 Jan 29. Neuropathol Appl Neurobiol. 2010. PMID: 20132489 Free PMC article.
-
What amyloid ligands can tell us about molecular polymorphism and disease.Neurobiol Aging. 2016 Jun;42:205-12. doi: 10.1016/j.neurobiolaging.2016.03.019. Epub 2016 Mar 24. Neurobiol Aging. 2016. PMID: 27143437 Free PMC article. Review.
-
Does beta-amyloid plaque formation cause structural injury to neuronal processes?Neurotox Res. 2005;7(1-2):5-15. doi: 10.1007/BF03033772. Neurotox Res. 2005. PMID: 15639794 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical